Thallium [201Tl] Chloride

氯化亚铊[201Tl]

Report date: 2025/11/25 17:06:32

Base Information

Drug NameThallium [201Tl] Chloride
Drug Alias NameThallium Chloride [201Tl]Thallous (Tl201) chloride
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Thallium > 201TIDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsHyperparathyroidismAtherosclerosisMyocardial Infarction +[6] 
Global Approved IndicationsMyocardial InfarctionCardiomyopathies
Approved Indications in ChinaCardiomyopathies
Original Approved Country/TerritoryUnited States
Original Approved Date1977/12/16
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesCurium PharmaMallinckrodt Medical BvHta Co Ltd
Inactive CompaniesLantheus Medical Imaging Inc
Active IndicationsHyperparathyroidismAtherosclerosisMyocardial Infarction +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A